Dr. Sheraz Gul
Dr Sheraz Gul is Head of Drug Discovery at the Fraunhofer Institute, Hamburg, Germany. He is responsible for the global management of drug discovery activities and has 23 years’ experience in both academia (University of London) and industry (GlaxoSmithKline Pharmaceuticals). This has ranged from the detailed study of catalysis by biological catalysts (enzymes and catalytic antibodies) to the design and development of assays for High Throughput Screening for the major drug target classes. His accomplishments include publications and opinion pieces, book chapters, the Enzyme Assays: Essential Data handbook, drafting patents and contracts and is an advisor to a number of biotech companies. Since 2011, he has organised Drug Discovery workshops across the globe (Brazil, Germany, Ireland, Italy, Portugal, Saudi Arabia and U.S.A) and trained over 400 scientists. In addition, he has been appointed to the editorial board of the European Pharmaceutical Review and Drug Target Review.